MolecuLight Announces Availability of its MolecuLight i:X® Platform on Epic’s App Orchard

Save MolecuLight i:X fluorescence wound images and measurements in Epic
Toronto, CANADA – (August 12, 2020) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announces the availability of its MolecuLight i:X® platform on the Epic App Orchard Marketplace and the integration of its platform with Epic’s leading EMR (electronic medical record) platform.

Users who use Epic for the treatment of wounds can upload standard and fluorescence images, and measurements captured with the MolecuLight i:X device at the point-of-care to the patient’s record. The integrated platforms allow clinicians to optimize their workflow and document their patients’ wounds digitally. The MolecuLight i:X application – iX Imaging – is available on the App Orchard.

“We are proud to announce the inclusion of our MolecuLight i:X platform in the Epic App Orchard Marketplace to allow customers to generate and access documentation of patients’ wounds”, says Anil Amlani, MolecuLight’s CEO. “The MolecuLight i:X is the only point-of-care device enabling clinicians to capture wound images showing clinically significant bacteria, information that improves clinical decision making to ensure the fastest path to healing. The integration of this additional information into existing documentation protocols will provide clinicians with a more complete wound dataset.” … read more

AmnioText from Regenative Labs

AmnioText™ patches are produced from human amniotic membranes and can be placed on the wound closure sites after a medical procedure or directly onto an open wound. The allografts are minimally manipulated and undergo an extensive and comprehensive testing process. The patches are produced in our first-class, state-of-the-art lab in Pensacola, Florida, to ensure the highest quality tissue allografts available. Click here to request more information